Carol R. Regueiro, MD, MSc, of Allegheny Health Network, highlights how the Physician Partners of Western PA practice support ...

New treatments for Alzheimer disease don’t reverse cognitive symptoms, but they do significantly slow progression. Evidence suggests that earlier treatment is most effective.

Illuminating the Future: Dr Kristen Whitney on What's Next for Dermoscopy ...

Although Bruton tyrosine kinase (BTK) inhibitor monotherapy in chronic lymphocytic leukemia (CLL) has been a game-changer, ...

THRAP3, STMN1, and GNA13—are overrepresented in blood cancers like acute myeloid leukemia (AML) and could prove to be novel ...

Patients with myelodysplastic syndromes (MDS) report more frequent symptoms than their physicians, according to a new report.

Cardiovascular disease is a major cause of death in MPN patients, with heart disease being the most prevalent type. Age, race ...

US drug shortages have decreased from 323 to 277 as of September 2024, yet many essential drugs remain scarce, with 50% of ...

When resistance to or failure of hypomethylating agents (HMAs) occurs in acute myeloid leukemia (AML), depleting a ligase ...

New legislation would clarify rules around value-based contracts in Medicaid, and a new model is expanding access to gene therapies, explained Adam Colborn, JD, of AMCP.

Health care costs continue to rise despite lower demand, while younger generations increasingly face chronic health ...

The long-term response rate for zanubrutinib was better than ibrutinib in patients with relapsed/refractory chronic ...